Please login to the form below

Not currently logged in
Email:
Password:

Kiadis Pharma appoints new chief operations officer

Jan Feijen joins the company from Janssen

Dutch company Kiadis Pharma has appointed Jan Feijen as its new chief operations officer with responsibility for manufacturing, supply chain, QA and project management.

Feijen arrives at Kiadis Pharma from Janssen where he was vice president manufacturing and technical operations, platform lead vaccines and advanced therapies.

He said: “I am very pleased to be joining Kiadis Pharma at this important time in its development. With the company’s pivotal phase III trial with ATIR101 now underway, it is vital that the necessary steps are taken to ensure everything continues to run smoothly and that we have all logistics in hand ready to roll out commercially in the future.”

Prior to his time at Janssen, Feijen held positions for the likes of Crucell, Avebe and Gist Brocades.

Arthur Lahr, CEO at Kiadis Pharma, said: “We are very pleased that an industry leader like Jan has accepted this opportunity to join Kiadis Pharma. His vast experience in pharma production precedes him, and his experience in running complex, just-in-time logistics will be of great value in scaling up our patient specific supply chain.”

21st March 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

The 2019 WHO essential medicine list: Narrowing the access gap to innovative cancer treatments
The essential medicine list (EML) contains treatments considered to be the most effective and safe in targeting global health concerns. On 9 July 2019, the World Health Organization (WHO) published...
NICE
Evolution or revolution: the latest review of NICE methods
By Leela Barham...
PRO
Integrating patient reported outcomes into clinical trials
How capturing the patient voice is unlocking medicines’ commercial potential...

Infographics